1905
華紙
+0.05 (+0.38%)13.101,486成交張數–本益比0.84股價淨值比0.00%殖利率2026-09-16資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率
營業收入202518,767年增 -9.6%
毛利率20252.7%最新一期
營業利益率2025-8.1%最新一期
每股盈餘2025-0.56
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 銷貨收入 | – | +2.5% | +5.6% | -13.7% | -10.2% | +18.0% | +7.3% | -11.0% | -1.0% | -10.0% | |
| 銷貨退回 | – | -50.3% | -17.9% | +15.1% | -30.2% | +7.3% | +18.9% | +72.2% | -3.0% | +40.7% | |
| 銷貨收入淨額 | – | +3.2% | +5.8% | -13.9% | -10.0% | +18.1% | +7.3% | -11.5% | -1.0% | -10.5% | |
| 其他營業收入淨額 | – | -10.6% | +14.7% | -21.4% | -1.0% | +125.5% | +23.8% | -1.0% | +17.6% | +106.7% | |
| 營業收入合計 | – | +3.2% | +5.8% | -13.9% | -10.0% | +18.3% | +7.3% | -11.4% | -0.9% | -9.6% | |
| 銷貨成本 | – | +1.5% | +6.2% | -10.1% | -10.8% | +12.8% | +7.5% | -5.8% | -3.2% | -4.9% | |
| 其他營業成本 | – | -44.8% | +125.5% | -25.7% | +19.5% | +99.3% | +2.9% | -21.3% | -3.3% | -49.9% | |
| 營業成本合計 | – | +1.4% | +6.3% | -10.2% | -10.8% | +13.0% | +7.5% | -5.8% | -3.2% | -5.0% | |
| 生物資產當期公允價值減出售成本之變動利益(損失) | – | – | – | – | – | +919.5% | -170.8% | – | – | -398.9% | |
| 營業毛利（毛損） | – | +22.4% | +1.2% | -48.2% | +2.4% | +93.5% | +6.2% | -57.3% | +41.8% | -67.4% | |
| 營業毛利（毛損）淨額 | – | +22.4% | +1.2% | -48.2% | +2.4% | +93.5% | +6.2% | -57.3% | +41.8% | -67.4% | |
| 推銷費用 | – | +1.7% | +1.5% | -8.2% | +5.8% | +40.5% | +10.5% | -20.6% | +10.2% | -10.8% | |
| 管理費用 | – | +1.2% | +34.0% | -9.4% | -5.6% | +10.1% | -10.3% | -4.3% | +4.3% | +45.0% | |
| 研究發展費用 | – | +21.4% | +387.7% | -13.0% | -7.6% | -11.5% | +42.7% | +19.2% | -8.5% | -22.7% | |
| 營業費用合計 | – | +1.9% | +15.3% | -8.9% | +2.2% | +30.5% | +8.5% | -15.7% | +7.5% | -3.0% | |
| 營業利益（損失） | – | +105.7% | -25.8% | -165.3% | – | – | -11.7% | -457.1% | – | – | |
| 利息收入 | – | – | – | – | – | -30.1% | +109.9% | +135.5% | +25.3% | -11.9% | |
| 其他收入 | – | +21.8% | +18.8% | +20.3% | -13.3% | +66.3% | -23.3% | +10.4% | +18.5% | +16.5% | |
| 其他利益及損失淨額 | – | – | -293.9% | – | – | – | – | -124.3% | – | – | |
| 財務成本淨額 | – | +10.0% | +12.0% | -0.2% | +4.9% | -6.4% | +62.3% | +62.2% | +18.8% | +17.0% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | – | -53.2% | +173.9% | -107.0% | – | – | +73.9% | -27.8% | +13.9% | +10.8% | |
| 營業外收入及支出合計 | – | – | -16.4% | -72.5% | +305.8% | +190.9% | +20.6% | -47.4% | +52.6% | +211.2% | |
| 稅前淨利（淨損） | – | +165.6% | -24.8% | -154.5% | – | – | +3.8% | -228.3% | – | – | |
| 所得稅費用（利益）合計 | – | – | -14.3% | -144.4% | – | +588.2% | -91.5% | – | – | – | |
| 繼續營業單位本期淨利（淨損） | – | +107.7% | -27.1% | -157.1% | – | – | +16.5% | -202.7% | – | – | |
| 本期淨利（淨損） | – | +107.7% | -27.1% | -157.1% | – | – | +16.5% | -202.7% | – | – | |
| 確定福利計畫之再衡量數 | – | – | – | – | – | – | – | -159.4% | – | -11.3% | |
| 透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益 | – | – | – | +418.8% | -90.1% | +866.4% | -102.2% | – | +13.5% | +112.9% | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-不重分類至損益之項目 | – | – | – | – | -32.4% | +262.2% | -89.8% | +715.1% | +26.5% | +109.4% | |
| 與不重分類之項目相關之所得稅 | – | – | – | – | – | – | – | -159.4% | – | -13.9% | |
| 不重分類至損益之項目： | – | – | – | – | -86.7% | +541.6% | -83.5% | +659.3% | +30.2% | +106.8% | |
| 國外營運機構財務報表換算之兌換差額 | – | – | – | – | – | – | – | -138.2% | – | -148.3% | |
| 避險工具之損益 | – | – | – | – | -55.5% | +896.0% | -100.0% | – | – | +66.5% | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目 | – | – | – | – | – | – | – | -116.9% | – | -227.3% | |
| 後續可能重分類至損益之項目： | – | – | – | – | – | – | – | -137.0% | – | -147.8% | |
| 其他綜合損益（淨額） | – | – | – | – | +15.3% | +370.1% | +89.9% | -32.8% | +282.1% | -19.6% | |
| 本期綜合損益總額 | – | – | +13.8% | -155.4% | – | – | +37.5% | -135.5% | – | -85.4% | |
| 母公司業主（淨利∕損） | – | +58.2% | -28.0% | -155.0% | – | – | -8.7% | -228.6% | – | – | |
| 非控制權益（淨利∕損） | – | – | -40.0% | -188.2% | – | – | – | -79.8% | +56.9% | -158.0% | |
| 母公司業主（綜合損益） | – | – | +22.5% | -126.2% | – | – | +11.6% | -138.7% | – | -69.1% | |
| 非控制權益（綜合損益） | – | – | -64.8% | -801.6% | – | – | – | -116.5% | – | -143.1% | |
| 基本每股盈餘 | – | +60.0% | -28.6% | -155.0% | – | – | -8.9% | -229.3% | – | – | |
| 繼續營業單位淨利（淨損） | – | +60.0% | -28.6% | -155.0% | – | – | -8.9% | -229.3% | – | – | |
| 稀釋每股盈餘 | – | +60.0% | -28.6% | -100.0% | – | – | -8.9% | -229.3% | – | – | |
| 共同控制下前手權益（淨利∕損） | – | – | – | -100.0% | – | – | – | – | – | – | |
| 共同控制下前手權益（綜合損益） | – | – | – | -100.0% | – | – | – | – | – | – | |
| 備供出售金融資產未實現評價損益 | – | – | – | – | – | – | – | – | – | – | |
| 現金流量避險中屬有效避險部分之避險工具利益(損失) | – | – | -100.0% | – | – | – | – | – | – | – | |
| 採用權益法認列關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目 | – | – | – | – | – | – | – | – | – | – | |
| 其他收益 | – | – | – | – | – | – | – | – | – | – | |
| 其他收益及費損淨額 | – | – | – | – | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。